Dr. Reddys Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Quarterly Results    (REDY)

Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dr. Reddys Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m38,64640,29638,58248,12843,97144,48944,26549,109 
Other income Rs m1,0238334,301540673736871512 
Turnover Rs m39,66941,12942,88348,66844,64445,22545,13649,621 
Expenses Rs m30,60032,10731,16537,49046,85834,99733,05237,548 
Gross profit Rs m8,0468,1897,41710,638-2,8879,49211,21311,561 
Depreciation Rs m2,9032,8722,8903,1312,8692,7412,9233,165 
Interest Rs m241245298303152230233252 
Profit before tax Rs m5,9255,9058,5307,744-5,2357,2578,9288,656 
Tax Rs m1,0111,5081,928-3,207325-4493,0591,011 
Profit after tax Rs m4,9144,3976,60210,951-5,5607,7065,8697,645 
Gross profit margin %20.820.319.222.1-6.621.325.323.5 
Effective tax rate %17.125.522.6-41.4-6.2-6.234.311.7 
Net profit margin %12.710.917.122.8-12.617.313.315.6 
Diluted EPS Rs 29.7 26.5 39.8 66.1 -33.6 46.5 35.4 46.1  
Diluted EPS (TTM) Rs 105.4 115.5 126.6 162.1 98.9 118.9 114.5 94.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Dr. Reddys 3QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   SANOFI INDIA  ORCHID PHARMA  GSK PHARMA  SUVEN LIFE SCIENCES  NOVARTIS  

Compare DR. REDDYS LAB With:   SANOFI INDIA  ORCHID PHARMA  GSK PHARMA  SUVEN LIFE SCIENCES  NOVARTIS  

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Views on news

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks (Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond (Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell (Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond (Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jan 25, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - SHASUN PHARMA COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS